Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Novo Nordisk Withdraws Wegovy FDA Heart Failure Submission, Terminates Development Of Two Early Stage Assets
August 07, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVO
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates
August 07, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Amgen's MariTide Weight Loss Potential: Stock Outlook
August 07, 2024
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
AMGN
LLY
NVO
XLV
Tesla Recalls 1.7M Vehicles In China Over Concerns Of Front Trunk Opening When Driving, After Recalling 1.8M Vehicles In US Over Similar Problems: To Fix Issue Via Over-The-Air Software Upgrade
August 07, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
YouthBio Therapeutics Announces Significant Results from Joint Study with Dr. Ocampo Demonstrating Amelioration of Age-Related Cognitive Decline
August 06, 2024
Via
PRLog
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Actuated Medical Developing Technology to Improve Targeting for Next-Generation Alcohol Use Disorder Treatments
August 06, 2024
Via
PRLog
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
Mental Health Watchdog Urges FDA to Ban Electroshock Device
August 05, 2024
Via
PRLog
Topics
Death
Lawsuit
Exposures
Death
Financial
Legal
Mental Health Watchdog Urges FDA to Ban Electroshock Device
August 05, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
JRE Offers Highly Durable Crimping Machines at Reasonable Rates
August 06, 2024
Via
Get News
Exposures
Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Submits New CNM-Au8 Biomarker, Clinical Efficacy Data to FDA
August 06, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Senators Press FDA To Approve MDMA As PTSD Treatment, Stressing US Vets' Suicide Rates As Aug 11 Decision Looms
August 06, 2024
Via
Benzinga
Exposures
Product Safety
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q2 2024 Financial Results, Earnings Conference Call
August 06, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
LGVN
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of AL001 involving Patients with Bipolar Disorder and Alzheimer's Disease
August 06, 2024
Via
News Direct
Exposures
Product Safety
Tickers
ALZN
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
August 06, 2024
Via
PressReach
Exposures
Product Safety
Tickers
ABBV
ALZN
ITCI
TEVA
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder and Alzheimer’s Disease
August 06, 2024
Via
PressReach
Exposures
Product Safety
Tickers
ALZN
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder
August 06, 2024
Via
PressReach
Exposures
Product Safety
Tickers
ALZN
Headline
August 06, 2024
Via
News Direct
Exposures
Product Safety
Tickers
ALZN
Delegate to Elevate Transforms Entrepreneurial Success Stories Through Strategic Outsourcing
August 05, 2024
Via
Prodigy
Topics
Product Recall
Exposures
Legal
Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Preparing for NDA Submission for Leading Drug Candidate
August 05, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PXMD
FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
IXHL
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ATNM
FDA Panel Backs Zevra's Arimoclomol For Rare Genetic Disorder, Analyst Highlights Balanced Portfolio Of Marketed Products And Pipeline Assets Focused On Rare Diseases
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ZVRA
EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ALZN
Intelligent Bio Solutions Inc. (Nasdaq: INBS) Announces Major Steps Towards FDA Clearance and U.S. Launch.
August 02, 2024
Via
AB Newswire
Exposures
Product Safety
Tickers
INBS
Lucid Stock Warning: LCID Offers Little Upside Ahead. Steer Clear.
August 02, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
LCID
TSLA
BioMedNewsBreaks — CEL-SCI Corp. (NYSE American: CVM) Closes on $10.8M Best-Efforts Offering
August 02, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CVM
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
August 02, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ADAP
GLPG
Boar’s Head Recalls 2024: 7 Million Pounds of Deli Meat, Poultry Pulled
July 31, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
FFIE
INTC
SAVE
Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels
July 31, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
ASML
FGEN
Zynex Inc. CEO Thomas Sandgaard Discusses Significant Company Growth and Future Innovations
July 31, 2024
Via
News Direct
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.